Notice to Clarify Other Submission Requirements for the 2010 NIDA Translational Avant-Garde Award for Medication Development for Diseases of Addiction, PAR-10-095 and RFA-DA-10-013

---

Notice Number: NOT-DA-10-011

Key Dates
Release Date: February 18, 2010

Issued by
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov)

Purpose

The purpose of this Notice is to clarify language regarding the proper formatting of the PD/PI biosketch found in Section IV.6. Other Submission Requirements of the Pre-Application for the 2010 NIDA Translational Avant-Garde Award for Medication Development for Diseases of Addiction (X02), PAR-10-095 (http://grants.nih.gov/grants/guide/pa-files/PAR-10-095.html)  and the 2010 NIDA Translational Avant-Garde Award for Medication Development for Diseases of Addiction (DP1), RFA-DA-10-013 (http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-10-013.html).

Specifically,

1. The biosketch should contain Section A (Personal Statement), Section B (Positions and Honors), and Section C (Peer-reviewed publications or manuscripts in press (in chronological order)).
2. The biosketch should not contain Section D (Research Support).
3. The biosketch is limited to two pages in length.

Other sections of the FOAs remain unchanged.

Inquiries

For further information contact:

Elena Koustova, Ph.D.
Division of Basic Neuroscience and Behavioral Research
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Blvd
Rm 4282 MSC 9555
Bethesda, MD 20892
Telephone: 301-496-8768
Fax: 301-594-6043
Email: [email protected]

Nora Chiang, Ph.D.
Division of Pharmacotherapies and Medical Consequences of Drug Abuse
Chemistry and Pharmaceutics Branch
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Blvd
Rm 4123 MSC 9551
Bethesda, MD 20892
Telephone: 301-443-5280
Email: [email protected]

---

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

---